COIOSDeep risk insights through multi-disciplinary research across the globe
Abstract pattern of green and silver wavy lines
Item confirms Peer-reviewed Added

Multi-cancer early detection blood test detected 15.4% of stage I cancers

A methylation and protein blood test identified 50.9% of cancers across 21 tumour organ types at a specificity of 98.5%, in a multi-centre case-control study of 6,352 samples.

A methylation and protein classifier was tested on 6,352 samples, 1,438 of them cancers, across 21 tumour organ types and all stages. Overall sensitivity was 50.9% at a specificity of 98.5%, measured against known cancers rather than a screening population. Sensitivity was 15.4% at stage I, rising to 85.5% at stage IV.

Why it is interesting: The test detected most late-stage cancers but fewer than one in six at stage I.

Source
Cancer Epidemiology, Biomarkers & Prevention, 2 October 2026
Paper
Performance of a multi-biomarker class, multi-cancer early detection (MCED) blood test in a prospectively collected cohort
Authors
Gainullin VG, Manesse M, Zhuang F, Gray M, Hwang HJ, Cerqueira GC et al.
DOI
10.1158/1055-9965.epi-26-0541
Type
Peer-reviewed article
Design
Multi-centre prospectively collected case-control study, 6,352 samples (1,438 cancers, 21 organ types), split into training and test sets
Verdict
Confirms prior evidence
Driver
Cancer
Driver
What linked data reveals
Free full text
Free to read at the publisher
Attention
1 citation (Crossref) · as of 2026-10-31

Other drivers in Health today